Get started
Author

Bo Yu

Observed names: B Yu, B. Yu, Yu Bo, Yu, Bo
Observed institutions: Lincoln Medical Center, Shanghai Medical College of Fudan University, NewYork–Presbyterian Hospital, NewYork–Presbyterian Brooklyn Methodist Hospital, Harbin Medical University, University of California, San Francisco, Jilin University, Cornell University, Fudan University, Columbia University Irving Medical Center, Chinese PLA General Hospital, Fudan University Shanghai Cancer Center, The Military General Hospital of Beijing PLA, Inner Mongolia People's Hospital, Pudong Medical Center, Second Affiliated Hospital of Harbin Medical University, Second Affiliated Hospital of Jilin University, Huashan Hospital, Weill Cornell Medicine, Weill Cornell Medical Center
ORCID: 0000-0002-7520-453X
Observed ORCID: 0000-0002-7520-453X
OpenAlex ID: A5102024940
BCMA-targeted immunotherapy for multiple myeloma
2020 · Bo Yu, Tianbo Jiang, et al. · Journal of Hematology & Oncology · 237
PDF
Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease
2020 · Jing Zou, Yue Guo, et al. · Neurotherapeutics · 95
PDF
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
2019 · Bo Yu, Delong Liu · Journal of Hematology & Oncology · 95
PDF
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
2020 · David J. Pinato, Takahiro Kaneko, et al. · Cancers · 77
PDF
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice
2021 · David J. Pinato, Thomas U. Marron, et al. · European Journal of Cancer · 64
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
2020 · Petros Fessas, Ahmed Kaseb, et al. · Journal for ImmunoTherapy of Cancer · 60
PDF
Gemtuzumab ozogamicin and novel antibody-drug conjugates in clinical trials for acute myeloid leukemia
2019 · Bo Yu, Delong Liu · Biomarker Research · 57
PDF
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
2020 · David J Pinato, Ahmed Kaseb, et al. · Journal for ImmunoTherapy of Cancer · 37
PDF
Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China
2022 · Yongchen Hao, Dong Zhao, et al. · JAMA Cardiology · 33
PDF
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis
2022 · Xiaoling Wu, Shaobo Cao, et al. · Blood Coagulation & Fibrinolysis · 29
Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits
2021 · Bo Yu, Victor Perez Gutierrez, et al. · Biomarker Research · 29
PDF
Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
2011 · Xi-Qing Ji, Xin-Jian Ruan, et al. · Medical Science Monitor · 25
Predictive Value of Cardiovascular Health Score for Health Outcomes in Patients with PCI: Comparison between Life’s Simple 7 and Life’s Essential 8
2023 · Xueqin Gao, Xinrui Ma, et al. · International Journal of Environmental Research and Public Health · 24
PDF
New Ultrasound-Controlled Paclitaxel Releasing Balloon vs. Asymmetric Drug-Eluting Stent in Primary ST-Segment Elevation Myocardial Infarction ― A Prospective Randomized Trial ―
2021 · Zhiyong Wang, Yuxia Yin, et al. · Circulation Journal · 23
PDF
Not All Plaque Erosions Are Equal
2019 · Jiannan Dai, Chao Fang, et al. · JACC. Cardiovascular imaging · 21
PDF
Non-islet cell tumor hypoglycemia as an initial presentation of hepatocellular carcinoma coupled with end-stage liver cirrhosis: A case report and review of literature
2020 · Bo Yu, Rana Douli, et al. · World Journal of Hepatology · 19
Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention
2017 · Weijie Bei, Hualong Li, et al. · Scientific Reports · 13
PDF
Pre-infarction angina and culprit lesion morphologies in patients with a first ST-segment elevation acute myocardial infarction: insights from in vivo optical coherence tomography
2019 · Rong Sun, Sining Hu, et al. · EuroIntervention · 10
The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
2022 · Shengliang Liu, Yunling Li, et al. · Frontiers in Cardiovascular Medicine · 6
PDF
Classification of Culprit Ruptured Plaque Morphologies in Patients With STEMI
2019 · Chao Wang, Sining Hu, et al. · JACC. Cardiovascular imaging · 5
Empiric use of Anticoagulation in Hospitalized Patients with COVID-19: A Propensity Score-Matched Study of Risks and Benefits
2021 · Bo Yu, Victor Perez Gutierrez, et al. · Research Square · 4
PDF
Wnt1-overexpressing skeletal myoblasts as an improved cell therapy for cardiac repair following myocardial infarction.
2015 · G Q Du, W J Du, et al. · PubMed · 4
Triglyceride–glucose index in the associations between chronic low-grade inflammation and carotid intima-media thickness: mediation and effect-modification across triglyceride–glucose strata
2025 · Xueguang Lin, Shishuai Xie, et al. · BMC Cardiovascular Disorders · 3
PDF
Prognostic Significance of Biventricular and Biatrial Strain in Dilated Cardiomyopathy: Strain Analysis Derived from Cardiovascular Magnetic Resonance
2023 · Shengliang Liu, Yunling Li, et al. · Reviews in Cardiovascular Medicine · 3
PDF
Characteristics of coronary artery ectasia and accompanying plaques: an optical coherence tomography study
2023 · Huai Yu, Jiannan Dai, et al. · The International Journal of Cardiovascular Imaging · 3
PDF
Works count: 58
Citation count: 992
H-index: 16
I10-index: 18
Year
Topic
Type